Serum Vitamin D3 Level in Patients with Female Pattern Hair Loss

Overview

Journal Int J Trichology

Date 2016 Sep 15

PMID 27625563

Citations 11

Authors

Mahnaz Banihashemi

Yalda Nahidi

Naser Tayyebi Meibodi

Lida Jarahi

Mojgan Dolatkhah

Affiliations

Soon will be listed here.

Abstract

Background: Female pattern hair loss (FPHL) is the most common cause of alopecia in women, characterized by diffuse nonscarring hair loss in frontal, central, and parietal areas of the scalp. Pathophysiology of FPHL is still not well known, and it is probably a multifactorial genetic trait. FPHL is also observed in women without increased androgen levels, which raises the likelihood of androgen-independent mechanisms and explains the lack of response to antiandrogen treatments in some patients. Vitamin D is a factor that has recently been considered in dealing with these patients. The purpose of this study was to evaluate the serum levels of Vitamin D in patients with FPHL and compare it with healthy controls.

Methods: In this case-control study, 45 women with FPHL were evaluated as well as the same number of healthy women matched for age, hours spent under sunlight per day, and body mass index. Serum 25(OH) D3 level was measured using ELISA.

Results: 60% of FPHL patients were in 15-30 years old age group with the mean standard deviation (SD) age of 29.11 (7.30) years. In the majority of patients (66.7%), severity of hair loss was Ludwig I. Mean (SD) serum Vitamin D3 level in patient and control group was 13.45 (8.40) and 17.16 (8.96), respectively. T-test showed a significant difference between the two groups in terms of Vitamin D3 serum levels (P = 0.04).

Conclusions: This study indicated the correlation between the incidence of FPHL and decreased serum levels of Vitamin D3. It is recommended to evaluate serum Vitamin D3 levels as well as other hormone assays in these patients.

Citing Articles

Vitamin D deficiency in non-scarring and scarring alopecias: a systematic review and meta-analysis.

Yongpisarn T, Tejapira K, Thadanipon K, Suchonwanit P Front Nutr. 2024; 11:1479337.

PMID: 39416654 PMC: 11479915. DOI: 10.3389/fnut.2024.1479337.

Oral Vitamin D Treatment in Patients with Telogen Effluvium: Clinical and Dermoscopic Evaluation.

El-Tatawy R, Gheida S, Soliman G, Ismail M Int J Trichology. 2024; 15(5):183-190.

PMID: 39170090 PMC: 11335050. DOI: 10.4103/ijt.ijt_92_22.

mTOR signaling in hair follicle and hair diseases: recent progress.

Tu W, Cao Y, Sun M, Liu Q, Zhao H Front Med (Lausanne). 2023; 10:1209439.

PMID: 37727765 PMC: 10506410. DOI: 10.3389/fmed.2023.1209439.

Female Pattern Hair Loss: An Overview with Focus on the Genetics.

Ho C, Chen J, Hsu W, Yu S, Chen W, Chiu S Genes (Basel). 2023; 14(7).

PMID: 37510231 PMC: 10379895. DOI: 10.3390/genes14071326.

Prevalence of Iatrogenic Vitamin D Toxicity Among the Saudi Population of Vitamin D Users Due to Overcorrection.

Aljehani F, Qashqari M, Alghamdi M, Saadi A, Alreasini M, Alsolami E Cureus. 2023; 15(4):e37521.

PMID: 37193464 PMC: 10182715. DOI: 10.7759/cureus.37521.

References

Vegesna V, OKelly J, Uskokovic M, Said J, Lemp N, Saitoh T . Vitamin D3 analogs stimulate hair growth in nude mice. Endocrinology. 2002; 143(11):4389-96. DOI: 10.1210/en.2002-220118. View

Dowd D, MacDonald P . The 1,25-dihydroxyvitamin D3-independent actions of the vitamin D receptor in skin. J Steroid Biochem Mol Biol. 2010; 121(1-2):317-21. PMC: 4127032. DOI: 10.1016/j.jsbmb.2010.03.072. View

Amor K, Rashid R, Mirmirani P . Does D matter? The role of vitamin D in hair disorders and hair follicle cycling. Dermatol Online J. 2010; 16(2):3. View

Aktan S, Akarsu S, Ilknur T, Demirtasoglu M, Ozkan S . Quantification of female pattern hair loss: a study in a Turkish population. Eur J Dermatol. 2007; 17(4):321-4. DOI: 10.1684/ejd.2007.0208. View

Demay M . The hair cycle and Vitamin D receptor. Arch Biochem Biophys. 2011; 523(1):19-21. DOI: 10.1016/j.abb.2011.10.002. View

Wadhwa B, Relhan V, Goel K, Kochhar A, Garg V . Vitamin D and skin diseases: A review. Indian J Dermatol Venereol Leprol. 2015; 81(4):344-55. DOI: 10.4103/0378-6323.159928. View

Zhang X, Caulloo S, Zhao Y, Zhang B, Cai Z, Yang J . Female pattern hair loss: clinico-laboratory findings and trichoscopy depending on disease severity. Int J Trichology. 2012; 4(1):23-8. PMC: 3358934. DOI: 10.4103/0974-7753.96082. View

Mostafa W, Hegazy R . Vitamin D and the skin: Focus on a complex relationship: A review. J Adv Res. 2015; 6(6):793-804. PMC: 4642156. DOI: 10.1016/j.jare.2014.01.011. View

Atanaskova Mesinkovska N, Bergfeld W . Hair: what is new in diagnosis and management? Female pattern hair loss update: diagnosis and treatment. Dermatol Clin. 2012; 31(1):119-27. DOI: 10.1016/j.det.2012.08.005. View

10.

Su L, Chen L, Chen H . Factors associated with female pattern hair loss and its prevalence in Taiwanese women: a community-based survey. J Am Acad Dermatol. 2012; 69(2):e69-77. DOI: 10.1016/j.jaad.2012.09.046. View

11.

Mirmirani P . Managing hair loss in midlife women. Maturitas. 2012; 74(2):119-22. DOI: 10.1016/j.maturitas.2012.10.020. View

12.

Jackson A, Price V . How to diagnose hair loss. Dermatol Clin. 2012; 31(1):21-8. DOI: 10.1016/j.det.2012.08.007. View

13.

Bolland M, Ames R, Grey A, Horne A, Mason B, Gamble G . Does degree of baldness influence vitamin D status?. Med J Aust. 2008; 189(11-12):674-5. DOI: 10.5694/j.1326-5377.2008.tb02241.x. View

14.

J Malloy P, Feldman D . The role of vitamin D receptor mutations in the development of alopecia. Mol Cell Endocrinol. 2011; 347(1-2):90-6. PMC: 3196847. DOI: 10.1016/j.mce.2011.05.045. View

15.

Rasheed H, Mahgoub D, Hegazy R, El-Komy M, Abdel Hay R, Hamid M . Serum ferritin and vitamin d in female hair loss: do they play a role?. Skin Pharmacol Physiol. 2013; 26(2):101-7. DOI: 10.1159/000346698. View

16.

Venning V, Dawber R . Patterned androgenic alopecia in women. J Am Acad Dermatol. 1988; 18(5 Pt 1):1073-7. DOI: 10.1016/s0190-9622(88)70108-5. View